Protara Therapeutics
TARA
45 hedge funds and large institutions have $141M invested in Protara Therapeutics in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 6 reducing their positions, and 2 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 6
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
11% more capital invested
Capital invested by funds: $126M → $141M (+$14.4M)
2% more funds holding
Funds holding: 44 → 45 (+1)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$352K |
| 2 |
Principal Financial Group
Des Moines,
Iowa
|
+$114K |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$79.2K |
| 4 |
State Street
Boston,
Massachusetts
|
+$72.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$57.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$1.04M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$439K |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$206K |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$25.2K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
-$12.3K |
TARA Hedge Fund Activity: Q4 2015 in Review
45 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Protara Therapeutics (TARA) for Q4 2015, worth a combined $141M — up 11% from $126M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new TARA positions and 2 closed out — a net gain of 1 holder — while 15 added to existing stakes and 6 trimmed.
The largest buyer was Baker Bros. Advisors, adding an estimated $352K. The largest seller was Tiverton Asset Management, cutting an estimated $1.04M.
- 45 institutional investors held Protara Therapeutics (TARA) as of Q4 2015, up from 44 in Q3 2015.
- Funds reported $141M of Protara Therapeutics stock for Q4 2015, up 11% quarter-over-quarter.
- 3 funds opened new Protara Therapeutics positions in Q4 2015 and 2 closed out, a net change of +1 holder.
- The largest Protara Therapeutics buyer in Q4 2015 was Baker Bros. Advisors, an estimated $352K added.
- The largest Protara Therapeutics seller in Q4 2015 was Tiverton Asset Management, an estimated $1.04M sold.
Based on aggregated 13F filings for Q4 2015.